Immunization against the agent of human granulocytic ehrlichiosis in a murine model

W Sun1, J W IJdo, S R Telford

  • 1Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

Insights

Antibodies offer partial protection against human granulocytic ehrlichiosis (HGE), a tick-borne disease. Vaccination and antiserum provided some immunity in a mouse model, suggesting antibodies are key but not fully protective.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Tick-borne Pathogens

Background:

  • Human granulocytic ehrlichiosis (HGE) is caused by a newly identified tick-borne pathogen.
  • The pathogen infects polymorphonuclear leukocytes, and a mouse model partially mimics human disease, exhibiting transient neutropenia.

Purpose of the Study:

  • To investigate the potential for immunity against the agent of HGE (aoHGE).
  • To evaluate the protective role of antibodies in immunity against aoHGE.

Main Methods:

  • C3H/HeN mice were infected via syringe inoculation or tick-borne transmission.
  • Mice were vaccinated with purified aoHGE lysates or administered aoHGE antisera.
  • Vaccinated and control mice were challenged with aoHGE via syringe or tick exposure.

Main Results:

  • Mice infected with aoHGE developed transient neutropenia, mimicking human HGE.
  • Vaccination with aoHGE lysates or administration of aoHGE antisera conferred partial protection against both syringe- and tick-transmitted aoHGE.
  • Complete immunity was not achieved, indicating limitations of antibody-mediated protection.

Conclusions:

  • Antibodies play a significant role in providing immunity against aoHGE.
  • Antibodies alone are sufficient for substantial but incomplete protection against HGE infection.
  • Further research is needed to achieve complete immunity against this tick-borne pathogen.

Related Concept Videos